HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ESRRB
estrogen related receptor beta
Chromosome 14 Β· 14q24.3
NCBI Gene: 2103Ensembl: ENSG00000119715.15HGNC: HGNC:3473UniProt: A0A2R8Y491
68PubMed Papers
21Diseases
0Drugs
27Pathogenic Variants
FUNCTIONAL ROLE
ReceptorTranscription Factor
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
sequence-specific double-stranded DNA bindingregulation of DNA-templated transcriptionsequence-specific DNA bindingnucleoplasmhearing loss, autosomal recessivedeafnessRare genetic deafnesshearing loss
✦AI Summary

ESRRB (estrogen-related receptor beta) is an orphan nuclear receptor transcription factor that binds canonical estrogen-related receptor elements (ERREs) with the sequence 5'TCAAGGTCA-3' in gene promoters and enhancers 1. It functions as a key regulator of pluripotency and stem cell self-renewal, playing critical roles during early embryonic development and in pluripotent stem cell populations 2. ESRRB also acts as a mitotic bookmarking factor and regulates cellular metabolism to maintain pluripotent stem cell identity 2. In naive pluripotent states, ESRRB cooperates with transposable element-derived MIR enhancers to regulate pluripotency genes through 3D chr14 interactions 3. Beyond development, ESRRB has emerged as a critical oncogenic factor. In cervical cancer, ESRRB drives cell proliferation by activating SMAD7 transcription, inhibiting TGFΞ² signaling and promoting cell-cycle progression through a positive feedback loop with MYC 4. In acute lymphoblastic leukemia (ALL), ESRRB cooperates with glucocorticoid receptor (GR) to mediate glucocorticoid gene expression; ESRRB knockdown induces GC resistance, while ESRRB agonists enhance GC sensitivity 1. Additionally, TMBPF exposure induces ovarian granulosa cell senescence through ESRRB/p21 signaling upregulation 5. Clinically, ESRRB variants are associated with autosomal recessive deafness (DFNB35) and represent a novel candidate gene for inherited retinal diseases 6. ESRRB is also implicated in Meniere's disease genetic architecture through rare variants 7.

Sources cited
1
ESRRB drives cervical cancer cell proliferation by activating SMAD7 to inhibit TGFΞ² signaling and promote cell-cycle progression
PMID: 37350664
2
ESRRB cooperates with glucocorticoid receptor to mediate glucocorticoid gene expression in ALL; ESRRB knockdown causes GC resistance
PMID: 32658986
3
ESRRB binds MIR enhancers and regulates 3D chromatin topology in naive pluripotent states to maintain pluripotency gene networks
PMID: 40296153
4
ESRRB identified as novel candidate gene for inherited retinal diseases in WES analysis of 491 IRD cases
PMID: 37798099
5
TMBPF exposure induces ovarian granulosa cell senescence by promoting ESRRB/p21 signaling
PMID: 40014986
6
ESRRB functions in early development, pluripotency maintenance, and reprogramming; acts as mitotic bookmarking factor and regulates cellular metabolism
PMID: 28834535
7
ESRRB rare variants are part of the genetic architecture contributing to Meniere's disease
PMID: 31874721
Disease Associationsβ“˜21
hearing loss, autosomal recessiveOpen Targets
0.70Strong
deafnessOpen Targets
0.59Moderate
Rare genetic deafnessOpen Targets
0.39Weak
hearing lossOpen Targets
0.37Weak
Non-syndromic genetic deafnessOpen Targets
0.37Weak
nonsyndromic genetic hearing lossOpen Targets
0.37Weak
inflammation of heart layerOpen Targets
0.32Weak
alopecia areataOpen Targets
0.31Weak
Hearing impairmentOpen Targets
0.30Weak
occlusion precerebral arteryOpen Targets
0.28Weak
corneal neovascularizationOpen Targets
0.28Weak
strokeOpen Targets
0.27Weak
cervical carcinomaOpen Targets
0.27Weak
tooth diseaseOpen Targets
0.27Weak
hyperpituitarismOpen Targets
0.26Weak
liver diseaseOpen Targets
0.26Weak
neurodegenerative diseaseOpen Targets
0.26Weak
thyroid cancerOpen Targets
0.23Weak
Premature ovarian insufficiencyOpen Targets
0.11Weak
DNA methylationOpen Targets
0.10Weak
Deafness, autosomal recessive, 35UniProt
Pathogenic Variants27
NM_001379180.1(ESRRB):c.851-2A>TLikely pathogenic
ESRRB-related disorder|not provided
β˜…β˜…β˜†β˜†2024
NM_001379180.1(ESRRB):c.*1451C>GLikely pathogenic
Autosomal recessive nonsyndromic hearing loss 35
β˜…β˜…β˜†β˜†2024
NM_001379180.1(ESRRB):c.923dup (p.Ile309fs)Pathogenic
not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 309
NM_001379180.1(ESRRB):c.1335_1336del (p.Phe446fs)Pathogenic
Autosomal recessive nonsyndromic hearing loss 35
β˜…β˜†β˜†β˜†2026β†’ Residue 446
NM_001379180.1(ESRRB):c.752del (p.Pro251fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2026β†’ Residue 251
NM_001379180.1(ESRRB):c.976T>C (p.Tyr326His)Likely pathogenic
Monogenic hearing loss
β˜…β˜†β˜†β˜†2025β†’ Residue 326
NM_001379180.1(ESRRB):c.933C>A (p.Tyr311Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 311
NM_001379180.1(ESRRB):c.*1451C>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2025
NM_001379180.1(ESRRB):c.834G>C (p.Trp278Cys)Likely pathogenic
Autosomal recessive nonsyndromic hearing loss 35
β˜…β˜†β˜†β˜†2025β†’ Residue 278
NM_001379180.1(ESRRB):c.688+1G>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2024
NM_001379180.1(ESRRB):c.577+2T>CLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2024
NM_001379180.1(ESRRB):c.661C>T (p.Gln221Ter)Pathogenic
Autosomal recessive nonsyndromic hearing loss 35
β˜…β˜†β˜†β˜†2023β†’ Residue 221
NM_001379180.1(ESRRB):c.738T>G (p.Tyr246Ter)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 246
NM_001379180.1(ESRRB):c.498C>A (p.Cys166Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 166
NM_001379180.1(ESRRB):c.808C>T (p.Arg270Ter)Likely pathogenic
Rare genetic deafness
β˜…β˜†β˜†β˜†2017β†’ Residue 270
NM_001379180.1(ESRRB):c.1011dup (p.Leu338fs)Likely pathogenic
Rare genetic deafness
β˜…β˜†β˜†β˜†2016β†’ Residue 338
NM_001379180.1(ESRRB):c.1088_1089del (p.Val363fs)Likely pathogenic
Rare genetic deafness
β˜…β˜†β˜†β˜†2015β†’ Residue 363
NM_004452.3(ESRRB):c.(?_1)_(1527_?)delLikely pathogenic
Rare genetic deafness
β˜…β˜†β˜†β˜†2014
NM_004452.3(ESRRB):c.(?_1501)_(1527_?)del (p.?)Likely pathogenic
Rare genetic deafness
β˜…β˜†β˜†β˜†2013
NM_001379180.1(ESRRB):c.1268_1272del (p.Thr423fs)Likely pathogenic
Rare genetic deafness
β˜…β˜†β˜†β˜†2013β†’ Residue 423
View on ClinVar β†—
Related Genes
POU5F1Protein interaction100%NCOR2Protein interaction100%KLF4Protein interaction99%SOX2Protein interaction98%NR0B1Protein interaction92%SALL4Protein interaction92%
Tissue Expression6 tissues
Heart
100%
Brain
2%
Lung
1%
Liver
1%
Ovary
0%
Bone Marrow
0%
Gene Interaction Network
Click a node to explore
ESRRBPOU5F1NCOR2KLF4SOX2NR0B1SALL4
PROTEIN STRUCTURE
Preparing viewer…
PDB6LIT Β· 2.00 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.56Moderately Constrained
pLIβ“˜
0.79Intermediate
Observed/Expected LoF0.37 [0.25–0.56]
RankingsWhere ESRRB stands among ~20K protein-coding genes
  • #6,898of 20,598
    Most Researched68
  • #1,906of 5,498
    Most Pathogenic Variants27
  • #3,634of 17,882
    Most Constrained (LOEUF)0.56 Β· top quartile
Genes detectedESRRB
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
ESRRB Inhibits the TGFΞ² Signaling Pathway to Drive Cell Proliferation in Cervical Cancer.
PMID: 37350664
Cancer Res Β· 2023
1.00
2
ESRRB regulates glucocorticoid gene expression in mice and patients with acute lymphoblastic leukemia.
PMID: 32658986
Blood Adv Β· 2020
0.90
3
Rewiring of SINE-MIR enhancer topology and Esrrb modulation in expanded and naive pluripotency.
PMID: 40296153
Genome Biol Β· 2025
0.80
4
Whole exome sequencing of 491 individuals with inherited retinal diseases reveals a large spectrum of variants and identification of novel candidate genes.
PMID: 37798099
J Med Genet Β· 2024
0.70
5
Tetramethyl bisphenol F exposure induces human ovarian granulosa cell senescence and mouse ovarian damage by regulating ESRRB signalling.
PMID: 40014986
Ecotoxicol Environ Saf Β· 2025
0.60